Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02112201 · ClinicalTrials.gov registry record · NA
The ProGirls Study
A NA study of Substance Use and Delinquency, sponsored by Oregon Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 416
- Enrollment target
- 1
- Study location
NCT02112201: Completed NA study of Substance Use and Delinquency, sponsored by Oregon Research Institute.
NCT02112201 is a NA study of Substance Use and Delinquency that has completed, run by Oregon Research Institute. The registered enrollment target is 416 participants, below the 1,256-participant average among 88 other Substance Use trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02112201, a NA study of Substance Use and Delinquency, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 416 participants
- Enrollment target
- 1
- Study location
Study Summary
Girls in the juvenile justice system who have high rates of delinquency, drug abuse, and trauma are particularly at risk for engaging in risky sexual behavior and for contracting HIV/AIDS or other sexually transmitted infections (STIs). No effective prevention programs for girls who have this combination of behaviors is known to exist at this time. Researchers are developing, assessing, and implementing a family-centered prevention program to decrease girls' participation in the risky behaviors associated with the spread of HIV and STIs. The program also includes a group-based training and support program for parents.
Primary Outcome
Girls in the intervention condition are expected to have significantly lower rates of HIV/STI risk behaviors compared to girls in the control condition at each of the time-points post-baseline. Data will be collected through in-person interviews and questionnaires from focal participants and their parents.
Conditions Studied
Interventions
- BEHAVIORAL Integrated intervention for parents and adolescent girls
Study Locations (1)
Oregon
- Oregon Research Institute - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2013-09 |
| Est. Completion | 2020-05 |
| Phase | NA |
What the finished NCT02112201 record still lists
NCT02112201 is an interventional study that assigns participants to a tested intervention. The registered 416 participants enrollment target is mid-sized for trials with a published cap, below the 1,256-participant average among 88 other Substance Use trials with a reported enrollment target (67% lower).
The record links to 4 conditions, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which Integrated intervention for parents and adolescent girls is the first listed.
NCT02112201 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT02112201 about?
NCT02112201 is a clinical study titled "The ProGirls Study". Girls in the juvenile justice system who have high rates of delinquency, drug abuse, and trauma are particularly at risk for engaging in risky sexual behavior and for contracting HIV/AIDS or other sexually transmitted infections (STIs). No effective prevention programs for girls who have this combin...
What is the current status of trial NCT02112201?
This trial is currently completed. It is a NA study. The enrollment target is 416 participants. The study started on 2013-09. Estimated completion is 2020-05.
What conditions does trial NCT02112201 study?
This clinical trial studies the following conditions: Substance Use, Delinquency, HIV Risk, Trauma Exposure.
What interventions are being tested in trial NCT02112201?
The interventions under investigation include: Integrated intervention for parents and adolescent girls (BEHAVIORAL).
Who is sponsoring clinical trial NCT02112201?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02112201 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02112201's enrollment target sits among peer trials
416 24th of 88 higher than 65 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
- NCT06075745 · 416 participants · Phase 2
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia